[Being cardiologist at the time of SARS-CoV-2: what do not forget during the post-pandemic phase?]

Luigi Tarantini1, Pompilio Faggiano2, Alessandro Navazio3

  • 1U.O. Cardiologia, Ospedale Civile San Martino, Belluno.

Giornale Italiano Di Cardiologia (2006)
|July 21, 2020
PubMed

Insights

The COVID-19 epidemic in Italy has subsided, but risks remain. Maintaining cardiovascular health requires adapting prevention and rehabilitation strategies, emphasizing telehealth for lifestyle changes and remote patient care.

Area of Science:

  • Cardiology
  • Public Health
  • Infectious Diseases

Background:

  • The COVID-19 epidemic's acute phase in Italy appears to be over, but the virus persists, necessitating ongoing vigilance.
  • Cardiovascular risk factors, including obesity, diabetes, and smoking, are linked to severe COVID-19 outcomes.
  • The pandemic necessitates changes in cardiovascular prevention and rehabilitation due to risks of crowding and close contact.

Purpose of the Study:

  • To address the challenges posed by the ongoing COVID-19 pandemic to cardiovascular health.
  • To highlight the need for adapting cardiovascular prevention and rehabilitation strategies.
  • To advocate for the integration of telehealth in managing cardiovascular risk factors.

Main Methods:

  • Review of the current COVID-19 situation in Italy and its implications for public health.
  • Analysis of cardiovascular risk factors associated with severe COVID-19.
  • Discussion of the necessary reorganization of cardiovascular prevention and rehabilitation services.

Main Results:

  • The persistence of COVID-19 requires sustained public health measures and surveillance.
  • Unhealthy lifestyle-driven cardiovascular risk factors significantly increase COVID-19 severity.
  • Traditional cardiovascular care models require adaptation to minimize transmission risks.

Conclusions:

  • Telehealth initiatives are crucial for promoting healthy lifestyles in primary prevention.
  • Tele-monitoring and tele-rehabilitation programs are essential for secondary prevention in the new phase.
  • Adapting cardiovascular care is vital to mitigate the risk of worsening cardiovascular risk factor control.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
178
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
102
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
249
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
201
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
164
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
144